🔎 Trials Near Me

Home › Multiple Myeloma › Michigan › Warren

Pag-aaral pangklinika para sa Multiple Myeloma sa Warren, MI

4 pag-aaral para sa Multiple Myeloma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Warren (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Nagre-recruitPhase 2
  • Henry Ford Health Warren Hospital, Warren
Edad 12 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT02693535

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Nagre-recruitPhase 3
  • Henry Ford Health Warren Hospital, Warren
  • Henry Ford Madison Heights Hospital - Breast, Warren
  • Henry Ford Warren Hospital - GLCMS, Warren
  • at 3 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04566328

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Nagre-recruitPhase 3
  • Advanced Breast Care Center PLLC, Warren
  • Great Lakes Cancer Management Specialists-Macomb Professional Building, Warren
  • Macomb Hematology Oncology PC, Warren
  • at 4 pa
Lahat ng edad · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT05561387

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

Nagre-recruitPhase 3
  • Henry Ford St. John Hospital, Grosse Pointe Woods · 6 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT05243797

Pag-aaral para sa Multiple Myeloma sa ibang lungsod

Iba pang pag-aaral sa Warren

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.